Recognizing the extensive medical applications of STAMPs, C3J is developing the potential of STAMP technology to modulate the microbiome both within the oral cavity and for broader medical applications. Our acquisition in 2018 of the engineered phage platform from Synthetic Genomics, Inc., enriches our targeted antimicrobial approach to combat the urgent global public health threat of multidrug-resistant bacteria (Read the Press Release).

Medical Pipeline | Dental Pipeline